<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">Paradoxical embolism</z:e> due to <z:hpo ids='HP_0006548'>pulmonary arteriovenous malformations</z:hpo> is the main mechanism of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in patients with hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>International Guidelines have recently been published to clarify the performance of screening tests and the effectiveness of treatment for <z:hpo ids='HP_0006548'>pulmonary arteriovenous malformations</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE PRESENTATION: We present two cases of hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> patients of our hospital who experienced an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> secondary to <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">paradoxical embolism</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSIONS: These two cases show that the guidelines must be followed to prevent the occurrence of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in patients with hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, and that although they may be adequate in most cases, there are some patients who need a more personalized approach </plain></SENT>
</text></document>